CellCentric (@cellcentric) 's Twitter Profile
CellCentric

@cellcentric

Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.

ID: 86965335

linkhttp://www.cellcentric.com calendar_today02-11-2009 15:37:37

643 Tweet

683 Takipçi

382 Takip Edilen

CellCentric (@cellcentric) 's Twitter Profile Photo
CellCentric
@cellcentric

3 years ago

PODCAST: cellcentric.com/wp-content/upl… Discusses recent inobrodib clinical trial data with key opinion leaders and hears from a multiple myeloma patient.

PODCAST: cellcentric.com/wp-content/upl… Discusses recent inobrodib clinical trial data with key opinion leaders and hears from a multiple myeloma patient.